IP Library Granted Patent US 10,674,945
Granted Patent B2
US 10,674,945 · App. 15/715,535 · Granted Jun 9, 2020

Real time modeling of analyte transport in a medium surrounding an implanted sensor to calculate a corresponding concentration of analyte in a distant medium

Inventors: Xiaoxiao Chen (Washington, DC); Andrew Dehennis (Germantown, MD)
Assignee: Senseonics, Incorporated
A61B5/14503A61B5/076A61B5/14532A61B5/6861A61B5/746A61B5/7455A61B2560/0219A61B2562/0271A61B2562/162
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,674,945
App. No.
15/715,535
Granted
Jun 9, 2020
Kind
B2
Abstract

An analyte monitoring system and method. The analyte monitoring system may include an analyte sensor and a transceiver. The analyte sensor may include an indicator element that exhibits one or more detectable properties based on a concentration of an analyte in proximity to the indicator element. The transceiver may be configured to (i) receive measurement information from the analyte sensor, (ii) calculate the concentration of the analyte in proximity to the indicator element based on at least the received measurement information, and (iii) calculate a blood analyte concentration based on the calculated concentration of the analyte in proximity to the indicator element by (1) incorporating the calculated concentration of the analyte in proximity to the indicator element into a governing equation that models analyte transport over an interval, and (2) solving the governing equation. In some embodiments, the governing equation includes no more than two discrete boundary conditions.

Claims (25)

1. An analyte monitoring system comprising:

an analyte sensor including an indicator element that exhibits one or more detectable properties based on a concentration of an analyte in proximity to the indicator element; and

a transceiver configured to (i) receive measurement information from the analyte sensor, (ii) calculate the concentration of the analyte in proximity to the indicator element based on at least the received measurement information, and (iii) calculate a blood analyte concentration based on the calculated concentration of the analyte in proximity to the indicator element by (1) incorporating the calculated concentration of the analyte in proximity to the indicator element into a governing equation that models analyte transport over an interval, and (2) solving the governing equation;

wherein the governing equation includes no more than two discrete boundary conditions, and the interval has a first endpoint at an interface between a bloodstream and surrounding tissue and a second endpoint at the sensor.

2. The analyte monitoring system of claim 1 , wherein the two discrete boundary conditions include (1) a concentration of the analyte at the second endpoint being equal to the calculated concentration of the analyte in proximity to the indicator element, and (2) constant flux of the analyte at the second endpoint.

3. The analyte monitoring system of claim 1 , wherein the governing equation includes a parameter for a maximum attainable diffusivity of the analyte and a diffusivity controlling parameter.

4. The analyte monitoring system of claim 1 , wherein the governing equation relates a rate of change of the concentration of the analyte over time to a diffusivity of the analyte at a given location within the interval.

5. The analyte monitoring system of claim 1 , wherein the transceiver is configured to calculate the blood analyte concentration in real time, based on at least the calculated analyte concentration in proximity to the sensor.

6. The analyte monitoring system of claim 1 , wherein the medium surrounding the sensor is a fibrous capsule.

7. An analyte monitoring system comprising:

an analyte sensor including an indicator element that exhibits one or more detectable properties based on a concentration of an analyte in proximity to the indicator element; and

a transceiver configured to (i) receive measurement information from the analyte sensor, (ii) calculate the concentration of the analyte in proximity to the indicator element based on at least the received measurement information, and (iii) calculate a blood analyte concentration based on the calculated concentration of the analyte in proximity to the indicator element by (1) incorporating the calculated concentration of the analyte in proximity to the indicator element into a governing equation that models analyte transport over an interval, and (2) solving the governing equation;

wherein the governing equation includes no more than two discrete boundary conditions, and the governing equation and the boundary conditions are defined in the Cartesian coordinate system.

8. An analyte monitoring system comprising:

an analyte sensor including an indicator element that exhibits one or more detectable properties based on a concentration of an analyte in proximity to the indicator element and

a transceiver configured to (i) receive measurement information from the analyte sensor, (ii) calculate the concentration of the analyte in proximity to the indicator element based on at least the received measurement information, and (iii) calculate a blood analyte concentration based on the calculated concentration of the analyte in proximity to the indicator element by (1) incorporating the calculated concentration of the analyte in proximity to the indicator element into a governing equation that models analyte transport over an interval, and (2) solving the governing equation;

wherein the governing equation includes no more than two discrete boundary conditions, the governing equation accounts for consumption of the analyte, and the governing equation includes a maximum rate of consumption parameter.

9. The analyte monitoring system of claim 8 , wherein the interval has a first endpoint at an interface between a bloodstream and surrounding tissue and a second endpoint at the sensor.

10. The analyte monitoring system of claim 8 , wherein the governing equation includes a consumption rate controlling parameter.

11. The analyte monitoring system of claim 8 , wherein the governing equation accounts for consumption of the analyte using a Michaelis-Menten equation, and the consumption is defined in the Cartesian coordinate system.

12. An analyte monitoring system comprising:

an analyte sensor including an indicator element that exhibits one or more detectable properties based on a concentration of an analyte in proximity to the indicator element and

a transceiver configured to (i) receive measurement information from the analyte sensor, (ii) calculate the concentration of the analyte in proximity to the indicator element based on at least the received measurement information, and (iii) calculate a blood analyte concentration based on the calculated concentration of the analyte in proximity to the indicator element by (1) incorporating the calculated concentration of the analyte in proximity to the indicator element into a governing equation that models analyte transport over an interval, and (2) solving the governing equation;

wherein the governing equation includes no more than two discrete boundary conditions, and the transceiver is further configured to solve the governing equation numerically using a discretization process followed by a linear algebra process.

13. The analyte monitoring system of claim 12 , wherein the transceiver is configured to perform the discretization process using a finite difference method.

Assignments (12)
SECURITY INTEREST Recorded Sep 11, 2023
From: SENSEONICS, INCORPORATED
To: HERCULES CAPITAL, INC.
Reel/Frame 064866/0963 →
RELEASE OF SECURITY INTEREST Recorded Sep 7, 2023
From: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS COLLATERAL AGENT
To: SENSEONICS, INCORPORATED; SENSEONICS HOLDINGS, INC.
Reel/Frame 064834/0962 →
RELEASE OF SECURITY INTEREST Recorded Apr 14, 2023
From: ALTER DOMUS (US) LLC, AS COLLATERAL AGENT
To: SENSEONICS HOLDINGS, INC.; SENSEONICS, INCORPORATED
Reel/Frame 063338/0890 →
RELEASE OF SECURITY INTEREST IN PATENTS AND TRADEMARKS Recorded Aug 14, 2020
From: WILMINGTON SAVINGS FUND SOCIETY, FSB, COLLATERAL AGENT
To: SENSEONICS, INCORPORATED; SENSEONICS HOLDINGS, INC.
Reel/Frame 053498/0275 →
INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Aug 14, 2020
From: SENSEONICS, INCORPORATED
To: ALTER DOMUS (US) LLC, AS COLLATERAL AGENT
Reel/Frame 053496/0292 →
INTELLECTUAL PROPERTY SECURITY AGREEMENT - FIRST LIEN Recorded Apr 24, 2020
From: SENSEONICS, INCORPORATED; SENSEONICS HOLDINGS, INC.
To: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS COLLATERAL AGENT
Reel/Frame 052492/0109 →
INTELLECTUAL PROPERTY SECURITY AGREEMENT -SECOND LIEN Recorded Apr 24, 2020
From: SENSEONICS, INCORPORATED; SENSEONICS HOLDINGS, INC.
To: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS COLLATERAL AGENT
Reel/Frame 052490/0160 →
RELEASE OF SECURITY INTEREST Recorded Mar 23, 2020
From: SOLAR CAPITAL LTD., AS AGENT
To: SENSEONICS, INCORPORATED
Reel/Frame 052207/0242 →
INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Aug 1, 2019
From: SENSEONICS, INCORPORATED
To: SOLAR CAPITAL LTD., AS AGENT
Reel/Frame 049926/0827 →
RELEASE OF SECURITY INTEREST Recorded Jul 25, 2019
From: OXFORD FINANCE LLC, AS COLLATERAL AGENT AND AS LENDER
To: SENSEONICS, INCORPORATED
Reel/Frame 049873/0713 →
SECURITY INTEREST Recorded Jan 26, 2018
From: SENSEONICS, INCORPORATED
To: OXFORD FINANCE LLC, AS COLLATERAL AGENT AND AS LENDER
Reel/Frame 045164/0154 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 27, 2017
From: CHEN, XIAOXIAO; DEHENNIS, ANDREW
To: SENSEONICS, INCORPORATED
Reel/Frame 043969/0888 →